The paradoxical role of inositol in cancer: a consequence of the metabolic state of a tumor

Lin, X., Xiao, Z., Chen, T., Liang, S. H., & Guo, H. (2020). Glucose metabolism on tumor plasticity, diagnosis, and treatment. Frontiers in Oncology, 10, 317. https://doi.org/10.3389/fonc.2020.00317

Article  PubMed  PubMed Central  Google Scholar 

Wei, Y., Huang, Y. H., Skopelitis, D. S., Iyer, S. V., Costa, A. S. H., Yang, Z., Kramer, M., Adelman, E. R., Klingbeil, O., Demerdash, O. E., Polyanskaya, S. A., Chang, K., Goodwin, S., Hodges, E., McCombie, W. R., Figueroa, M. E., & Vakoc, C. R. (2022). SLC5A3-dependent myo-inositol auxotrophy in acute myeloid leukemia. Cancer Discovery, 12(2), 450–467. https://doi.org/10.1158/2159-8290.CD-20-1849

Article  PubMed  Google Scholar 

Koguchi, T., Tanikawa, C., Mori, J., Kojima, Y., & Matsuda, K. (2016). Regulation of myo-inositol biosynthesis by p53-ISYNA1 pathway. International Journal of Oncology, 48(6), 2415–2424. https://doi.org/10.3892/ijo.2016.3456

CAS  Article  PubMed  Google Scholar 

Zhou, L., Sheng, W., Jia, C., Shi, X., Cao, R., Wang, G., Lin, Y., Zhu, F., Dong, Q., & Dong, M. (2020). Musashi2 promotes the progression of pancreatic cancer through a novel ISYNA1-p21/ZEB-1 pathway. Journal of cellular and molecular medicine, 24(18), 10560–10572. https://doi.org/10.1111/jcmm.15676

CAS  Article  PubMed  PubMed Central  Google Scholar 

Chhetri, D. R. (2019). Myo-inositol and its derivatives: Their emerging role in the treatment of human diseases [mini review]. Frontiers in Pharmacology, 10, 1172. https://doi.org/10.3389/fphar.2019.01172

CAS  Article  PubMed  PubMed Central  Google Scholar 

Suliman, M., Case, K. C., Schmidtke, M. W., Lazcano, P., Onu, C. J., & Greenberg, M. L. (2022). Inositol depletion regulates phospholipid metabolism and activates stress signaling in HEK293T cells. Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids, 1867(6), 159137. https://doi.org/10.1016/j.bbalip.2022.159137

CAS  Article  PubMed  Google Scholar 

Sadria, M., Seo, D., & Layton, A. T. (2022). The mixed blessing of AMPK signaling in cancer treatments. BMC Cancer, 22(1), 105. https://doi.org/10.1186/s12885-022-09211-1

CAS  Article  PubMed  PubMed Central  Google Scholar 

Jia, Z., & Wan, X. (2022). ISYNA1: An immunomodulatory-related prognostic biomarker in colon adenocarcinoma and pan-cancer [original research]. Frontiers in Cell and Developmental Biology, 10, 792564. https://doi.org/10.3389/fcell.2022.792564

Article  PubMed  PubMed Central  Google Scholar 

Guo, X., Li, H.-H., Hu, J., Duan, Y.-X., Ren, W.-G., Guo, Q., Liu, P.-H., Cui, Y., Liu, L.-F., & Chen, M.-F. (2019). ISYNA1 is overexpressed in bladder carcinoma and regulates cell proliferation and apoptosis. Biochemical and biophysical research communications, 519(2), 246–252. https://doi.org/10.1016/j.bbrc.2019.08.129

CAS  Article  PubMed  Google Scholar 

Bevilacqua, A., & Bizzarri, M. (2018). Inositols in insulin signaling and glucose metabolism. International Journal of Endocrinology, 2018, 1968450. https://doi.org/10.1155/2018/1968450

CAS  Article  PubMed  PubMed Central  Google Scholar 

Hsu, C. .-C., Zhang, X., Wang, G., Zhang, W., Cai, Z., Pan, B. .-S., Gu, H., Xu, C., Jin, G., & Xu, X. (2021). Inositol serves as a natural inhibitor of mitochondrial fission by directly targeting AMPK. Molecular Cell, 81(18), 3803-3819. e3807. https://doi.org/10.1016/j.molcel.2021.08.025

CAS  Article  PubMed  Google Scholar 

Hoxhaj, G., & Manning, B. D. (2020). The PI3K–AKT network at the interface of oncogenic signalling and cancer metabolism. Nature Reviews Cancer, 20(2), 74–88. https://doi.org/10.1038/s41568-019-0216-7

CAS  Article  PubMed  Google Scholar 

Bizzarri, M., Dinicola, S., Bevilacqua, A., & Cucina, A. (2016). Broad spectrum anticancer activity of myo-inositol and inositol hexakisphosphate. International Journal of Endocrinology, 2016, 5616807. https://doi.org/10.1155/2016/5616807

CAS  Article  PubMed  PubMed Central  Google Scholar 

Lazcano, P., Schmidtke, M. W., Onu, C., & Greenberg, M. L. (2022). Phosphatidic acid inhibits inositol synthesis by inducing nuclear translocation of IP6K1 and repression of myo-inositol-3-P synthase. bioRxiv, 2022.2002.2021.481348. https://doi.org/10.1101/2022.02.21.481348

留言 (0)

沒有登入
gif